Institutional investors purchased a net $3.5 million shares of ABMD during the quarter ended December 2014 and now own 94.30% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APEX CAPITAL MANAGEMENT, INC. Bought 49.0 Thousand shares of Abiomed Inc